questionsmedicales.fr
Composés chimiques organiques
Composés du soufre
Composés organothiophosphorés
Composés organothiophosphorés : Questions médicales fréquentes
Diagnostic
5
Intoxication
Tests sanguins
Cholinestérase
Analyse sanguine
Symptômes
Intoxication aiguë
Évaluation clinique
Antécédents médicaux
Cholinestérase
Marqueurs biologiques
Symptômes
5
Troubles neurologiques
Symptômes
Effets neurologiques
Convulsions
Effets à long terme
Troubles cognitifs
Intoxication sévère
Paralysie
Variabilité des symptômes
Voie d'exposition
Prévention
5
Prévention
Équipements de protection
Formation
Mesures de sécurité
Réglementation
Pesticides
Déversements
Procédures de décontamination
Pratiques agricoles
Alternatives
Traitements
5
Atropine
Traitement de l'intoxication
Traitement précoce
Pronostic
Soins de soutien
Oxygénothérapie
Complications
5
Complications
Intoxication
Effets réversibles
Séquelles
Gestion des complications
Suivi médical
Cancer
Exposition prolongée
Qualité de vie
Soins continus
Facteurs de risque
5
Agriculteurs
Travailleurs des pesticides
Facteurs environnementaux
Pesticides
Personnes âgées
Sensibilité
Mode de vie
Exposition aux pesticides
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés organothiophosphorés : Questions médicales les plus fréquentes",
"headline": "Composés organothiophosphorés : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés organothiophosphorés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-29",
"dateModified": "2026-08-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés organothiophosphorés"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés du soufre",
"url": "https://questionsmedicales.fr/mesh/D013457",
"about": {
"@type": "MedicalCondition",
"name": "Composés du soufre",
"code": {
"@type": "MedicalCode",
"code": "D013457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Organothiophosphates",
"alternateName": "Organothiophosphates",
"url": "https://questionsmedicales.fr/mesh/D063086",
"about": {
"@type": "MedicalCondition",
"name": "Organothiophosphates",
"code": {
"@type": "MedicalCode",
"code": "D063086",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Amifostine",
"alternateName": "Amifostine",
"url": "https://questionsmedicales.fr/mesh/D004999",
"about": {
"@type": "MedicalCondition",
"name": "Amifostine",
"code": {
"@type": "MedicalCode",
"code": "D004999",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.050"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Azinphos-méthyl",
"alternateName": "Azinphosmethyl",
"url": "https://questionsmedicales.fr/mesh/D001387",
"about": {
"@type": "MedicalCondition",
"name": "Azinphos-méthyl",
"code": {
"@type": "MedicalCode",
"code": "D001387",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorpyriphos",
"alternateName": "Chlorpyrifos",
"url": "https://questionsmedicales.fr/mesh/D004390",
"about": {
"@type": "MedicalCondition",
"name": "Chlorpyriphos",
"code": {
"@type": "MedicalCode",
"code": "D004390",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cystafos",
"alternateName": "Cystaphos",
"url": "https://questionsmedicales.fr/mesh/D003539",
"about": {
"@type": "MedicalCondition",
"name": "Cystafos",
"code": {
"@type": "MedicalCode",
"code": "D003539",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.130"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diazinon",
"alternateName": "Diazinon",
"url": "https://questionsmedicales.fr/mesh/D003976",
"about": {
"@type": "MedicalCondition",
"name": "Diazinon",
"code": {
"@type": "MedicalCode",
"code": "D003976",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diméthoate",
"alternateName": "Dimethoate",
"url": "https://questionsmedicales.fr/mesh/D004117",
"about": {
"@type": "MedicalCondition",
"name": "Diméthoate",
"code": {
"@type": "MedicalCode",
"code": "D004117",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.220"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Disulfoton",
"alternateName": "Disulfoton",
"url": "https://questionsmedicales.fr/mesh/D004222",
"about": {
"@type": "MedicalCondition",
"name": "Disulfoton",
"code": {
"@type": "MedicalCode",
"code": "D004222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.230"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Iodure d'écothiopate",
"alternateName": "Echothiophate Iodide",
"url": "https://questionsmedicales.fr/mesh/D004456",
"about": {
"@type": "MedicalCondition",
"name": "Iodure d'écothiopate",
"code": {
"@type": "MedicalCode",
"code": "D004456",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.240"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fénitrothion",
"alternateName": "Fenitrothion",
"url": "https://questionsmedicales.fr/mesh/D005278",
"about": {
"@type": "MedicalCondition",
"name": "Fénitrothion",
"code": {
"@type": "MedicalCode",
"code": "D005278",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fenthion",
"alternateName": "Fenthion",
"url": "https://questionsmedicales.fr/mesh/D005284",
"about": {
"@type": "MedicalCondition",
"name": "Fenthion",
"code": {
"@type": "MedicalCode",
"code": "D005284",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Malathion",
"alternateName": "Malathion",
"url": "https://questionsmedicales.fr/mesh/D008294",
"about": {
"@type": "MedicalCondition",
"name": "Malathion",
"code": {
"@type": "MedicalCode",
"code": "D008294",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Parathion",
"alternateName": "Parathion",
"url": "https://questionsmedicales.fr/mesh/D010278",
"about": {
"@type": "MedicalCondition",
"name": "Parathion",
"code": {
"@type": "MedicalCode",
"code": "D010278",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Parathion-méthyl",
"alternateName": "Methyl Parathion",
"url": "https://questionsmedicales.fr/mesh/D008743",
"about": {
"@type": "MedicalCondition",
"name": "Parathion-méthyl",
"code": {
"@type": "MedicalCode",
"code": "D008743",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.600.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Parathion-méthyl",
"alternateName": "Methyl Parathion",
"url": "https://questionsmedicales.fr/mesh/D008743",
"about": {
"@type": "MedicalCondition",
"name": "Parathion-méthyl",
"code": {
"@type": "MedicalCode",
"code": "D008743",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.600.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phorate",
"alternateName": "Phorate",
"url": "https://questionsmedicales.fr/mesh/D010702",
"about": {
"@type": "MedicalCondition",
"name": "Phorate",
"code": {
"@type": "MedicalCode",
"code": "D010702",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Téméfos",
"alternateName": "Temefos",
"url": "https://questionsmedicales.fr/mesh/D000002",
"about": {
"@type": "MedicalCondition",
"name": "Téméfos",
"code": {
"@type": "MedicalCode",
"code": "D000002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.692.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thiophosphonates",
"alternateName": "Organothiophosphonates",
"url": "https://questionsmedicales.fr/mesh/D063085",
"about": {
"@type": "MedicalCondition",
"name": "Thiophosphonates",
"code": {
"@type": "MedicalCode",
"code": "D063085",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.846"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fonofos",
"alternateName": "Fonofos",
"url": "https://questionsmedicales.fr/mesh/D004397",
"about": {
"@type": "MedicalCondition",
"name": "Fonofos",
"code": {
"@type": "MedicalCode",
"code": "D004397",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.846.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leptophos",
"alternateName": "Leptophos",
"url": "https://questionsmedicales.fr/mesh/D010773",
"about": {
"@type": "MedicalCondition",
"name": "Leptophos",
"code": {
"@type": "MedicalCode",
"code": "D010773",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.846.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "O-Éthyl-O-(4-nitrophényl)-phényl-phosphonothioate",
"alternateName": "Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester",
"url": "https://questionsmedicales.fr/mesh/D004849",
"about": {
"@type": "MedicalCondition",
"name": "O-Éthyl-O-(4-nitrophényl)-phényl-phosphonothioate",
"code": {
"@type": "MedicalCode",
"code": "D004849",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.300.846.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés organothiophosphorés",
"alternateName": "Organothiophosphorus Compounds",
"code": {
"@type": "MedicalCode",
"code": "D009946",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Loyd V Allen",
"url": "https://questionsmedicales.fr/author/Loyd%20V%20Allen",
"affiliation": {
"@type": "Organization",
"name": "International Journal of Pharmaceutical Compounding. lallen@ijpc.com."
}
},
{
"@type": "Person",
"name": "Irene Sánchez-Gavilán",
"url": "https://questionsmedicales.fr/author/Irene%20S%C3%A1nchez-Gavil%C3%A1n",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain."
}
},
{
"@type": "Person",
"name": "Yiming Liu",
"url": "https://questionsmedicales.fr/author/Yiming%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Qilu Hospital, Shandong University, Jinan, China."
}
},
{
"@type": "Person",
"name": "Pablo Rayff da Silva",
"url": "https://questionsmedicales.fr/author/Pablo%20Rayff%20da%20Silva",
"affiliation": {
"@type": "Organization",
"name": "Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil."
}
},
{
"@type": "Person",
"name": "Renan Fernandes do Espírito Santo",
"url": "https://questionsmedicales.fr/author/Renan%20Fernandes%20do%20Esp%C3%ADrito%20Santo",
"affiliation": {
"@type": "Organization",
"name": "Instituto Gonçalo Moniz, Fundação Osvaldo Cruz, Salvador 40296-710, BA, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The suitability of a polydimethylsiloxane-based (PDMS) microfluidic two compartment system for the toxicokinetic analysis of organophosphorus compounds.",
"datePublished": "2023-10-10",
"url": "https://questionsmedicales.fr/article/37827339",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.toxlet.2023.10.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Miro2 sulfhydration by CBS/H",
"datePublished": "2024-10-26",
"url": "https://questionsmedicales.fr/article/39461943",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-024-07167-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "A molecularly imprinted electrochemiluminescence sensor based on mimic enzyme ZIF-90 and MnO",
"datePublished": "2024-10-17",
"url": "https://questionsmedicales.fr/article/39420129",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00604-024-06753-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissipation Kinetics, Decontamination and Safety Evaluation of Quinalphos Residues in Cauliflower Curd.",
"datePublished": "2024-09-21",
"url": "https://questionsmedicales.fr/article/39306628",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00128-024-03954-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissipation behaviour and dietary risk evaluation of pesticides on cucumber.",
"datePublished": "2024-08-05",
"url": "https://questionsmedicales.fr/article/39098866",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10661-024-12926-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du soufre",
"item": "https://questionsmedicales.fr/mesh/D013457"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés organothiophosphorés",
"item": "https://questionsmedicales.fr/mesh/D009946"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés organothiophosphorés - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés organothiophosphorés",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-25",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés organothiophosphorés",
"description": "Comment diagnostiquer une intoxication aux organothiophosphorés ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une intoxication aiguë ?\nComment différencier entre les types d'intoxication ?\nQuels sont les marqueurs biologiques d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D009946#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés organothiophosphorés",
"description": "Quels sont les symptômes courants d'une exposition ?\nComment se manifestent les effets neurologiques ?\nY a-t-il des symptômes à long terme ?\nQuels signes indiquent une intoxication sévère ?\nLes symptômes varient-ils selon le type de composé ?",
"url": "https://questionsmedicales.fr/mesh/D009946#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés organothiophosphorés",
"description": "Comment prévenir l'exposition aux organothiophosphorés ?\nQuelles sont les recommandations pour les travailleurs ?\nLes pesticides organothiophosphorés sont-ils réglementés ?\nComment gérer les déversements accidentels ?\nQuelles sont les bonnes pratiques agricoles ?",
"url": "https://questionsmedicales.fr/mesh/D009946#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés organothiophosphorés",
"description": "Quel est le traitement principal pour l'intoxication ?\nComment la décontamination est-elle réalisée ?\nQuels antidotes sont disponibles ?\nQuelle est l'importance du traitement précoce ?\nY a-t-il des traitements de soutien ?",
"url": "https://questionsmedicales.fr/mesh/D009946#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés organothiophosphorés",
"description": "Quelles complications peuvent survenir après une intoxication ?\nLes effets sont-ils réversibles ?\nComment les complications sont-elles gérées ?\nY a-t-il des risques de cancer associés ?\nLes complications peuvent-elles affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D009946#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés organothiophosphorés",
"description": "Qui est le plus à risque d'exposition ?\nLes enfants sont-ils plus vulnérables ?\nQuels facteurs environnementaux augmentent le risque ?\nLes personnes âgées sont-elles à risque ?\nComment le mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009946#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux organothiophosphorés ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour mesurer les niveaux d'enzymes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de cholinestérase et des analyses de sang peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aiguë ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, des convulsions et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Comment différencier entre les types d'intoxication ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation clinique et les antécédents d'exposition aident à distinguer les types d'intoxication."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs biologiques d'exposition ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de cholinestérase dans le sang sont des marqueurs clés d'exposition aux organothiophosphorés."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des troubles respiratoires et des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les effets neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets neurologiques peuvent inclure des tremblements, des convulsions et une confusion mentale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes à long terme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets neurologiques persistants et des troubles cognitifs peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une intoxication sévère ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intoxication sévère peut se manifester par des spasmes musculaires, une paralysie et un coma."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de composé ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la structure chimique et la voie d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux organothiophosphorés ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité lors de l'utilisation."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les travailleurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs doivent être formés aux risques et aux mesures de sécurité appropriées."
}
},
{
"@type": "Question",
"name": "Les pesticides organothiophosphorés sont-ils réglementés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est réglementée pour minimiser les risques pour la santé humaine et l'environnement."
}
},
{
"@type": "Question",
"name": "Comment gérer les déversements accidentels ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les déversements doivent être nettoyés immédiatement avec des procédures de décontamination appropriées."
}
},
{
"@type": "Question",
"name": "Quelles sont les bonnes pratiques agricoles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter des pratiques agricoles durables et utiliser des alternatives aux organothiophosphorés quand possible."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'atropine est souvent administrée pour contrer les effets des organothiophosphorés."
}
},
{
"@type": "Question",
"name": "Comment la décontamination est-elle réalisée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La décontamination implique le lavage de la peau et des yeux, et l'élimination des vêtements contaminés."
}
},
{
"@type": "Question",
"name": "Quels antidotes sont disponibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "En plus de l'atropine, le pralidoxime peut être utilisé pour réactiver la cholinestérase."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance du traitement précoce ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce est crucial pour réduire la gravité des symptômes et améliorer le pronostic."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements de soutien ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins de soutien comme l'oxygénothérapie et la ventilation peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une intoxication ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, respiratoires et cardiovasculaires peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les effets sont-ils réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent entraîner des séquelles permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical et des traitements spécifiques selon les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien potentiel entre l'exposition prolongée et le cancer, mais les preuves sont limitées."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie et nécessiter des soins continus."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les agriculteurs, les travailleurs des pesticides et les personnes vivant près des zones agricoles sont à risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus vulnérables en raison de leur taille et de leur développement physiologique."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux augmentent le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "La proximité des champs traités et l'utilisation excessive de pesticides augmentent le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques en raison de la santé déclinante."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie exposé aux pesticides, comme le travail agricole, augmente le risque d'intoxication."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/08/2026
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
International Journal of Pharmaceutical Compounding. lallen@ijpc.com.
2 publications dans cette catégorie
Affiliations :
Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain.
Publications dans "Composés organothiophosphorés" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Qilu Hospital, Shandong University, Jinan, China.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Instituto Gonçalo Moniz, Fundação Osvaldo Cruz, Salvador 40296-710, BA, Brazil.
Faculdade de Farmácia, Universidade Federal da Bahia, Salvador 40170-290, BA, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Programa de Pós Graduação em Produtos Naturais, Sintéticos e Bioativos, Universidade Federal da Paraiba, João Pessoa 58051-900, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Instituto Gonçalo Moniz, Fundação Osvaldo Cruz, Salvador 40296-710, BA, Brazil.
Faculdade de Farmácia, Universidade Federal da Bahia, Salvador 40170-290, BA, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
Programa de Pós Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Laboratório de Ensaios Farmacológicos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande 58429-500, PB, Brazil.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830057, China.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830057, China.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830057, China.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830057, China.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830057, China.
Xinjiang Key Laboratory of Famous Prescription and Science of Formulas, Urumqi 830057, China.
Publications dans "Composés organothiophosphorés" :
1 publication dans cette catégorie
Affiliations :
College of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830057, China.
Xinjiang Key Laboratory of Famous Prescription and Science of Formulas, Urumqi 830057, China.
Publications dans "Composés organothiophosphorés" :
Organ-on-a-chip platforms are an emerging technology in experimental and regulatory toxicology (species-specific differences, ethical considerations). They address gaps between in vivo and in vitro mo...
Insufficient cytotrophoblast (CTB) migration and invasion into the maternal myometrium leads to pregnancy related complications like Intra-uterus Growth Restriction (IUGR), and pre-eclampsia (PE). We ...
Methidathion (MTDT), a common organophosphorus pesticide with high insecticidal activity, is widely used for pest control. However, the misuse of MTDT leads to widespread residues and endangers human ...
A field experiment was conducted to study the persistence and reduction of quinalphos residues in cauliflower curd by applying quinalphos 25 EC twice at 250 g a.i./ha at 10 days intervals. The limit o...
Cucumber (Cucumis sativus L.) is the world's most widely consumed salad vegetable, and it is frequently treated with pesticides to prevent pest and disease outbreaks. Pesticide residues in food commod...
Paclitaxel (PTX) is a chemotherapeutic agent affecting microtubule polymerization. The efficacy of PTX depends on the type of tumor, and its improvement would be beneficial in patients' treatment. The...
Practical uses for quantum computers are emerging in chemistry, promising to speed the development of materials, catalysts, and drugs....
Physical fatigue (peripheral fatigue), which affects a considerable portion of the world population, is a decline in the ability of muscle fibers to contract effectively due to alterations in the regu...
Osteoporosis is a global health challenge characterized by bone loss and microstructure deterioration, which urgently requires the development of safer and more effective treatments due to the signifi...
There is a need for validation methods to ensure the quality and consistency of reported data, but a recent article by Raymond and Girolami [Acta Cryst. (2023), C79, https://doi.org/10.1107/S205322962...